ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO248

Comparison Between a Novel Latex Immunoassay and LC-MS/MS for Hepcidin-25 Measurement

Session Information

Category: Anemia and Iron Metabolism

  • 202 Anemia and Iron Metabolism: Clinical

Authors

  • Kamei, Daigo, Tokyo Women's Medical University, Tokyo, Japan
  • Nagano, Masashi, Nerima Sakuradai Clinic, Tokyo, Japan
  • Hanafusa, Norio, Tokyo Women's Medical University, Tokyo, Japan
  • Mineshima, Michio, Tokyo Women's Medical University, Tokyo, Japan
  • Nitta, Kosaku, Tokyo Women's Medical University, Tokyo, Japan
  • Tsuchiya, Ken, Tokyo Women's Medical University, Tokyo, Japan
Background

Hepcidin-25 is an iron regulatory factor in the in vivo evaluation of iron dynamics and plays an important role in determining the development and severity of anemia in patients with chronic kidney disease.
Although the golden standard of measurement of hepcidin-25 is the LC-MS/MS method, results cannot be obtained immediately at the clinical site. However, the latex immunoassay (LIA) can be performed using general clinical laboratory equipment, and the results obtained quickly.
Our aim was to measure hepcidin-25 by LIA and LC-MS/MS and compare the two methods.

Methods

Hepcidin-25 was measured by LIA and LC-MS/MS in 134 hemodialysis patients. We used a hepcidin-25 specific reagent (FUJIFILM Wako Pure Chemical Corporation) and the JCA-BM6050 automatic analyzer for LIA and the 4000 QTRAP LC-MS/MS system for LC-MS/MS. The results obtained by the two methods were compared by standard major axis regression.

Results

The standard major axis regression equation between the two methods was y = 0.995x + 0.5 (r = 0.998, p < 0.001). The correlation between the two methods was very strong and the measured values were almost identical.

Conclusion

The performance of LIA was equivalent to that of LC-MS/MS for hepcidin-25 measurement. LIA can be performed using general clinical examination apparatus and has a higher processing speed than LC-MS/MS. Therefore, measurement of hepcidin-25 by LIA may potentially be useful for routine laboratory testing.